✦ LIBER ✦

A phase I trial of MK-0731, a Kinesin Spindle Protein (KSP) inhibitor, in patients with solid tumors

✍ Scribed by Kyle Holen, Robert DiPaola, Glenn Liu, Antoinette R. Tan, George Wilding, Karl Hsu, Nancy Agrawal, Cong Chen, Lingling Xue, Elizabeth Rosenberg, Mark Stein

Book ID: 113064506
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 242 KB
Volume: 30
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-011-9653-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of ispinesib, a kinesin

A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours

✍ Blagden, S P; Molife, L R; Seebaran, A; Payne, M; Reid, A H M; Protheroe, A S; V 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 150 KB

A Phase I trial of the kinesin spindle p

A Phase I trial of the kinesin spindle protein (Eg5) inhibitor AZD4877 in patients with solid and lymphoid malignancies

✍ John F. Gerecitano,Joe J. Stephenson,Nancy L. Lewis… 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 210 KB

640 POSTER Phase I study of ispinesib (S

640 POSTER Phase I study of ispinesib (SB-715992), a kinesin spindle protein inhibitor, in combination with capecitabine in patients with advanced solid tumors

✍ J. Rodon; E. Till; A. Patnaik; C. Takimoto; M. Beeram; D. Williams; C. Bowen; J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 55 KB

55 A phase I study of SB-715992, a novel

55 A phase I study of SB-715992, a novel kinesin spindle protein (KSP) inhibitor: pharmacokinetic (PK)/pharmacodynamic (PD) modeling of absolute neutrophil counts (ANC)

✍ D. Williams; S. Kathman; Q. Chu; K. Holen; E. Rowinsky; G. Wilding; P. Mudd; J. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 273 KB

A phase 1 dose-escalation study of ARRY-

A phase 1 dose-escalation study of ARRY-520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemias

✍ Hanna Jean Khoury; Guillermo Garcia-Manero; Gautam Borthakur; Tapan Kadia; Maria 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

Phase I dose escalation study of MK-0457

Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors

✍ Anne M. Traynor; Maureen Hewitt; Glenn Liu; Keith T. Flaherty; Jason Clark; Stev 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 252 KB